Despite the fact that DUSP1 and DUSP6 have been studied in detail and there are inhibitors available, further extensive work is needed to better understand the role of all ERK-targeting DUSPs within the various types of tumours and to develop DUSP modulators, both inhibitors and activators, for their utilization in the clinics. The gene discussed is DUSP5; the disease is neoplasm.